{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:47:01Z","timestamp":1790621221080,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is an inherited neurodegenerative disorder caused by a CAG repeat expansion within exon 1 of the huntingtin (<jats:italic>HTT<\/jats:italic>) gene. <jats:italic>HTT<\/jats:italic> mRNA contains 67 exons and does not always splice between exon 1 and exon 2 leading to the production of a small polyadenylated <jats:italic>HTTexon<\/jats:italic>1 transcript, and the full-length <jats:italic>HTT<\/jats:italic> mRNA has three 3\u2032UTR isoforms. We have developed a QuantiGene multiplex panel for the simultaneous detection of all of these mouse <jats:italic>Htt<\/jats:italic> transcripts directly from tissue lysates and demonstrate that this can replace the more work-intensive Taqman qPCR assays. We have applied this to the analysis of brain regions from the zQ175 HD mouse model and wild type littermates at two months of age. We show that the incomplete splicing of <jats:italic>Htt<\/jats:italic> occurs throughout the brain and confirm that this originates from the mutant and not endogenous <jats:italic>Htt<\/jats:italic> allele. Given that <jats:italic>HTTexon<\/jats:italic>1 encodes the highly pathogenic exon 1 HTT protein, it is essential that the levels of all <jats:italic>Htt<\/jats:italic> transcripts can be monitored when evaluating HTT lowering approaches. Our QuantiGene panel will allow the rapid comparative assessment of all <jats:italic>Htt<\/jats:italic> transcripts in cell lysates and mouse tissues without the need to first extract RNA.<\/jats:p>","DOI":"10.1038\/s41598-019-52411-2","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:03:34Z","timestamp":1573038214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay"],"prefix":"10.1038","volume":"9","author":[{"given":"Aikaterini S.","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casandra","family":"Gomez-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-463X","authenticated-orcid":false,"given":"Bridget A.","family":"Taxy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-6305","authenticated-orcid":false,"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"52411_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat Rev Dis Primers 1, 15005, https:\/\/doi.org\/10.1038\/nrdp.2015.5 (2015).","journal-title":"Nat Rev Dis Primers"},{"key":"52411_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntignton\u2019s Disease Collaborative Group","year":"1993","unstructured":"The Huntignton\u2019s Disease Collaborative Group. A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntingtons-Disease Chromosomes. Cell 72, 971\u2013983, https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E (1993).","journal-title":"Cell"},{"key":"52411_CR3","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein, D. C. et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 59, 16\u201322 (1996).","journal-title":"Am J Hum Genet"},{"key":"52411_CR4","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet 12, 3359\u20133367 (2003).","journal-title":"Hum Mol Genet"},{"key":"52411_CR5","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1073\/pnas.0800048105","volume":"105","author":"R Gonitel","year":"2008","unstructured":"Gonitel, R. et al. DNA instability in postmitotic neurons. Proc Natl Acad Sci USA 105, 3467\u20133472, https:\/\/doi.org\/10.1073\/pnas.0800048105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52411_CR6","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/hmg\/2.10.1541","volume":"2","author":"B Lin","year":"1993","unstructured":"Lin, B. et al. Differential 3\u2032 poly(A)denylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Hum Mol Genet 2, 1541\u20131545 (1993).","journal-title":"Hum Mol Genet"},{"key":"52411_CR7","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1016\/j.celrep.2017.09.009","volume":"20","author":"L Romo","year":"2017","unstructured":"Romo, L., Ashar-Patel, A., Pfister, E. & Aronin, N. Alterations in mRNA 3\u2032 UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington\u2019s Disease Brains. Cell Rep 20, 3057\u20133070, https:\/\/doi.org\/10.1016\/j.celrep.2017.09.009 (2017).","journal-title":"Cell Rep"},{"key":"52411_CR8","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci USA 110, 2366\u20132370, https:\/\/doi.org\/10.1073\/pnas.1221891110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52411_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06281-3","volume":"9","author":"A Neueder","year":"2018","unstructured":"Neueder, A., Dumas, A. A., Benjamin, A. C. & Bates, G. P. Regulatory mechanisms of incomplete huntingtin mRNA splicing. Nat Commun 9, 3955, https:\/\/doi.org\/10.1038\/s41467-018-06281-3 (2018).","journal-title":"Nat Commun"},{"key":"52411_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01510-z","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder, A. et al. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep 7, 1307, https:\/\/doi.org\/10.1038\/s41598-017-01510-z (2017).","journal-title":"Sci Rep"},{"key":"52411_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J., Ghosh, R. & Leavitt, B. R. Huntingtin Lowering Strategies for Disease Modification in Huntington\u2019s Disease. Neuron 101, 801\u2013819, https:\/\/doi.org\/10.1016\/j.neuron.2019.01.039 (2019).","journal-title":"Neuron"},{"key":"52411_CR12","doi-asserted-by":"publisher","unstructured":"Tabrizi, S. J. et al. Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease. N Engl J Med, https:\/\/doi.org\/10.1056\/NEJMoa1900907 (2019).","DOI":"10.1056\/NEJMoa1900907"},{"key":"52411_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"52411_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/hmg\/ddu504","volume":"24","author":"BA Barbaro","year":"2015","unstructured":"Barbaro, B. A. et al. Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington\u2019s disease. Hum Mol Genet 24, 913\u2013925, https:\/\/doi.org\/10.1093\/hmg\/ddu504 (2015).","journal-title":"Hum Mol Genet"},{"key":"52411_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nbt1236","volume":"24","author":"RD Canales","year":"2006","unstructured":"Canales, R. D. et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 24, 1115\u20131122, https:\/\/doi.org\/10.1038\/nbt1236 (2006).","journal-title":"Nat Biotechnol"},{"key":"52411_CR16","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1093\/nar\/25.15.2979","volume":"25","author":"ML Collins","year":"1997","unstructured":"Collins, M. L. et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules\/ml. Nucleic Acids Res 25, 2979\u20132984 (1997).","journal-title":"Nucleic Acids Res"},{"key":"52411_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2006.02.013","volume":"352","author":"M Flagella","year":"2006","unstructured":"Flagella, M. et al. A multiplex branched DNA assay for parallel quantitative gene expression profiling. Anal Biochem 352, 50\u201360, https:\/\/doi.org\/10.1016\/j.ab.2006.02.013 (2006).","journal-title":"Anal Biochem"},{"key":"52411_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/nat.2015.0578","volume":"26","author":"AH Coles","year":"2016","unstructured":"Coles, A. H. et al. A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo. Nucleic Acid Ther 26, 86\u201392, https:\/\/doi.org\/10.1089\/nat.2015.0578 (2016).","journal-title":"Nucleic Acid Ther"},{"key":"52411_CR19","doi-asserted-by":"publisher","unstructured":"Alterman, J. F. et al. A High-throughput Assay for mRNA Silencing in Primary Cortical Neurons in vitro with Oligonucleotide Therapeutics. Bio Protoc, 7, https:\/\/doi.org\/10.21769\/BioProtoc.2501 (2017).","DOI":"10.21769\/BioProtoc.2501"},{"key":"52411_CR20","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1038\/mtna.2015.38","volume":"4","author":"JF Alterman","year":"2015","unstructured":"Alterman, J. F. et al. Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain. Mol Ther Nucleic Acids 4, e266, https:\/\/doi.org\/10.1038\/mtna.2015.38 (2015).","journal-title":"Mol Ther Nucleic Acids"},{"key":"52411_CR21","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen, T. et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS One 7, e50717, https:\/\/doi.org\/10.1371\/journal.pone.0050717 (2012).","journal-title":"PLoS One"},{"key":"52411_CR22","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington\u2019s Disease: zQ175. PLoS One 7, e49838, https:\/\/doi.org\/10.1371\/journal.pone.0049838 (2012).","journal-title":"PLoS One"},{"key":"52411_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1326-3-17","volume":"3","author":"CL Benn","year":"2008","unstructured":"Benn, C. L., Fox, H. & Bates, G. P. Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington\u2019s disease. Mol Neurodegener 3, 17, https:\/\/doi.org\/10.1186\/1750-1326-3-17 (2008).","journal-title":"Mol Neurodegener"},{"key":"52411_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"G-H Consortium","year":"2015","unstructured":"Consortium, G.-H. Identification of Genetic Factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"52411_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/hmg\/ddy375","volume":"28","author":"R Goold","year":"2019","unstructured":"Goold, R. et al. FAN1 modifies Huntington\u2019s disease progression by stabilizing the expanded HTT CAG repeat. Hum Mol Genet 28, 650\u2013661, https:\/\/doi.org\/10.1093\/hmg\/ddy375 (2019).","journal-title":"Hum Mol Genet"},{"key":"52411_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","volume":"16","author":"DJH Moss","year":"2017","unstructured":"Moss, D. J. H. et al. Identification of genetic variants associated with Huntington\u2019s disease progression: a genome-wide association study. Lancet Neurol 16, 701\u2013711, https:\/\/doi.org\/10.1016\/S1474-4422(17)30161-8 (2017).","journal-title":"Lancet Neurol"},{"key":"52411_CR27","doi-asserted-by":"publisher","unstructured":"Franich, N. R. et al. Phenotype onset in Huntington\u2019s disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene. J Neurosci Res Epub https:\/\/doi.org\/10.1002\/jnr.24493 (2019).","DOI":"10.1002\/jnr.24493"},{"key":"52411_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/hmg\/ddp467","volume":"19","author":"K Sathasivam","year":"2010","unstructured":"Sathasivam, K. et al. Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington\u2019s disease. Hum Mol Genet 19, 65\u201378, https:\/\/doi.org\/10.1093\/hmg\/ddp467 (2010).","journal-title":"Hum Mol Genet"},{"key":"52411_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ymeth.2009.12.006","volume":"50","author":"SA Bustin","year":"2010","unstructured":"Bustin, S. A. Why the need for qPCR publication guidelines?\u2013The case for MIQE. Methods 50, 217\u2013226, https:\/\/doi.org\/10.1016\/j.ymeth.2009.12.006 (2010).","journal-title":"Methods"},{"key":"52411_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-11-74","volume":"11","author":"SA Bustin","year":"2010","unstructured":"Bustin, S. A. et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 11, 74, https:\/\/doi.org\/10.1186\/1471-2199-11-74 (2010).","journal-title":"BMC Mol Biol"},{"key":"52411_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408, https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"52411_CR32","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52411-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:26:04Z","timestamp":1671290764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52411-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52411"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52411-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16137"}}